Wall Street analysts forecast that Carlisle (CSL) will report quarterly earnings of $3.34 per share in its upcoming release, pointing to a year-over-year decline of 7.5%. It is anticipated that ...

Carlisle Companies is positioned for strong growth, driven by aging U.S. commercial roofs and stricter energy standards. Find ...

Carlisle Companies Incorporated (NYSE:CSL) is included among the 15 Cash-Rich Dividend Stocks to Invest in Right Now. Goldman ...

CSL’s growth slowed, and its premium valuation reset hard. The post What on earth's going on with CSL shares? appeared first ...

A casual enthusiast might tell you that BMW’s M-badged models are the company’s peak performance offerings. The true fans know that in reality, the rare CSL models are a cut above. In its latest video ...

Earlier this year, BMW debuted the M4 CS, a car designed to sit between the Competition Package and the ultra-hardcore M4 GTS. Of course, bringing back the CS designation, which stands for Coupe Sport ...

The market expects Carlisle (CSL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...